update
Clinerion expands coverage by 60m patients via strategic partnership
Clinerion has partnered with Provisio Inc. to expand its service coverage in the Americas by approximately 60m patients.
Archives for October 30, 2017
Concept acquires preclinical CRO following search to add translational biology capabilities
Concept Life Sciences has acquired Aquila BioMedical, citing the CRO’s specific skill set, which will allow the company to provide services in areas “not previously accessible,” says executive chairman.
EMA’s data publication policy a year in review: ‘Positive outcomes’ achieved via industry collaboration
A year after implementing its policy on the publication of clinical data, reports on 50 medicines have been published and more than 80,000 documents downloaded – outcomes achieved through industry collaboration, says EMA.
Curevac starts work on RNA-based drug plant with capacity for Lilly deal
Curevac AG has started building a RNA therapeutics plant in Tubingen, Germany.
InMed’s eye-catching cannabinoid ‘lense’ for drug delivery
InMed Pharmaceuticals is developing a gel-based cannabinoid drug for eye diseases such as glaucoma, which it says could be cheaper and more accessible than cannabinoid-based products on the market.
news in brief
US FDA accuses Vital Labs on network-wide oversight failings
The US FDA has accused Vital Laboratories of failing to adequately monitor and control API production at its network of manufacturing plants.
BIOPRODUCTION CONGRESS DUBLIN 2017
HPRA tells drug makers how to get ‘GMP inspection-ready’
Firms should identify risks prior to inspection, make staff available during regulator visits, and respond promptly post-inspection when undergoing GMP site checks, says Ireland’s Health Products Regulatory Authority (HPRA).